![Dimitar Savov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 95 M $ op 31-05-2026
Dimitar Slavchev Savov currently works at Nika Pharmaceuticals, Inc., as President, Chief Executive Officer, CFO & Director from 2022.
Mr. Savov also formerly worked at Nika BioTechnology, Inc., as Chairman & President.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NIKA PHARMACEUTICALS INC 43,45% | 18-03-2025 | 455.589.500 ( 43,45% ) | 92 M $ | 31-05-2026 |
| 31-12-2024 | 15.000.000 ( 100% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NIKA PHARMACEUTICALS, INC. | Algemeen Directeur | 01-04-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NIKA BIOTECHNOLOGY, INC. | Voorzitter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Nika BioTechnology, Inc.
 Nika BioTechnology, Inc. Precious MetalsNon-Energy Minerals Engages in exploration of for gold, silver and copper | Non-Energy Minerals |
Nika Pharmaceuticals, Inc.
 Nika Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes dietary supplements and antiviral drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
